Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dalia R. Al-Sharaky, Moshira Abdelwahed, Nancy Asaad, Amira Foda & Asmaa Gaber Abdou. (2021) Stratification of urinary bladder carcinoma based on immunohistochemical expression of CK5, CK14 and CK20. Journal of Immunoassay and Immunochemistry 42:3, pages 236-251.
Read now
Read now
Xin Gao, Wenwen Zheng, Lili Ye, Xiaohong Wen, Shunlan Wang, Hui Cao, Xi Liu, Denggao Huang, Fei Wang & Shufang Zhang. (2019) Exploration of bladder cancer-associated methylated miRNAs by methylated DNA immunoprecipitation sequencing. OncoTargets and Therapy 12, pages 6165-6174.
Read now
Read now
Christen Lykkegaard Andersen, Volkert Dirk Siersma, Hans Carl Hasselbalch, Hanne Lindegaard, Hanne Vestergaard, Peter Felding, Niels de Fine Olivarius & Ole Weis Bjerrum. (2014) Eosinophilia in routine blood samples as a biomarker for solid tumor development – A study based on The Copenhagen Primary Care Differential Count (CopDiff) Database. Acta Oncologica 53:9, pages 1245-1250.
Read now
Read now
. (2014) Retraction notice: Eosinophilia in routine blood samples as a biomarker for solid tumor development – A study based on The Copenhagen Primary Care Differential Count (CopDiff ) Database. Acta Oncologica 53:4, pages 576-576.
Read now
Read now
Articles from other publishers (17)
Periklis Koukourikis, Maria Papaioannou, Petros Georgopoulos, Ioannis Apostolidis, Stavroula Pervana & Apostolos Apostolidis. (2023) A Study of DNA Methylation of Bladder Cancer Biomarkers in the Urine of Patients with Neurogenic Lower Urinary Tract Dysfunction. Biology 12:8, pages 1126.
Crossref
Crossref
Raquel Benítez, Katherine Yu, Marina Sirota, Núria Malats & Silvia Pineda. (2023) Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer. Frontiers in Immunology 14.
Crossref
Crossref
Fabiana Cancrini, Floriane Michel, Olivier Cussenot, Hussa Alshehhi, Eva Comperat & Véronique Phé. (2022) Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?. World Journal of Urology 40:8, pages 1949-1959.
Crossref
Crossref
T. Setayesh, A. Nersesyan, M. Kundi, M. Mišík, M. Fenech, C. Bolognesi, H. Stopper, G. Parsadanyan, B. Ernst & S. Knasmueller. (2021) Impact of infections, preneoplasia and cancer on micronucleus formation in urothelial and cervical cells: A systematic review. Mutation Research/Reviews in Mutation Research 787, pages 108361.
Crossref
Crossref
Mukta Basu, Balarko Chakraborty, Sabnam Ghosh, Sudip Samadder, Sankhadeep Dutta, Anup Roy, Dilip Kumar Pal, Amlan Ghosh & Chinmay Kumar Panda. (2020) Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma. Mutagenesis 35:6, pages 499-508.
Crossref
Crossref
Mohamed S. Zaghloul, Tarek M. Zaghloul, Mai K. Bishr & Brian C. Baumann. (2020) Urinary schistosomiasis and the associated bladder cancer: update. Journal of the Egyptian National Cancer Institute 32:1.
Crossref
Crossref
Mukta Basu, Sabnam Ghosh, Anirban Roychowdhury, Sudip Samadder, Pijush Das, Sankar Addya, Anup Roy, Dilip Kumar Pal, Susanta Roychoudhury, Amlan Ghosh & Chinmay Kumar Panda. (2020) Integrative genomics and pathway analysis identified prevalent FA-BRCA pathway alterations in arsenic-associated urinary bladder carcinoma: Chronic arsenic accumulation in cancer tissues hampers the FA-BRCA pathway. Genomics 112:6, pages 5055-5065.
Crossref
Crossref
Naina Arora, Rimanpreet Kaur, Farhan Anjum, Shweta Tripathi, Amit Mishra, Rajiv Kumar & Amit Prasad. (2019) Neglected Agent Eminent Disease: Linking Human Helminthic Infection, Inflammation, and Malignancy. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Massimo Tonolini. 2018. Imaging and Intervention in Urinary Tract Infections and Urosepsis. Imaging and Intervention in Urinary Tract Infections and Urosepsis
155
172
.
Ronan Flippot, Gabriel G. Malouf, Xiaoping Su, David Khayat & Jean-Philippe Spano. (2016) Oncogenic viruses: Lessons learned using next-generation sequencing technologies. European Journal of Cancer 61, pages 61-68.
Crossref
Crossref
Bogdan CzerniakColin Dinney & David McConkey. (2016) Origins of Bladder Cancer. Annual Review of Pathology: Mechanisms of Disease 11:1, pages 149-174.
Crossref
Crossref
Nut Koonrungsesomboon, Anita Carolle Wadagni & Evaristus Chibunna Mbanefo. (2015) Molecular markers and Schistosoma-associated bladder carcinoma: A systematic review and meta-analysis. Cancer Epidemiology 39:4, pages 487-496.
Crossref
Crossref
André van der Merwe, Dedan Opondo & Amir Zarrabi. 2015. Tropical Hemato-Oncology. Tropical Hemato-Oncology
381
385
.
Sara BrennerEllis Tobin. 2013. The Clinical Nanomedicine Handbook. The Clinical Nanomedicine Handbook
1
84
.
J. Ferrís, O. Berbel, J. Alonso-López, J. Garcia & J.A. Ortega. (2013) Environmental non-occupational risk factors associated with bladder cancer. Actas Urológicas Españolas (English Edition) 37:9, pages 579-586.
Crossref
Crossref
J. Ferrís, O. Berbel, J. Alonso-López, J. Garcia & J.A. Ortega. (2013) Factores de riesgo ambientales no ocupacionales asociados al cáncer vesical. Actas Urológicas Españolas 37:9, pages 579-586.
Crossref
Crossref
Richard Morgan, Richard T. Bryan, Saqib Javed, Francesca Launchbury, Maurice P. Zeegers, K.K. Cheng, Nicholas D. James, D. Michael A. Wallace, Carolyn D. Hurst, Douglas G. Ward, Margaret A. Knowles & Hardev Pandha. (2013) Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer 49:9, pages 2214-2222.
Crossref
Crossref